These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 904502)

  • 1. Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"?
    Kapit RM
    Med Hypotheses; 1977; 3(5):207-10. PubMed ID: 904502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of striato-nigral GABAergic pathway by chronic haloperidol treatment: the role of dopamine D1 receptor in the substantia nigra pars reticulata on the development of tardive dyskinesia.
    Shirakawa O; Maeda K; Sakai K
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):429-30. PubMed ID: 8271625
    [No Abstract]   [Full Text] [Related]  

  • 3. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia.
    Scheel-Krüger J; Arnt J
    Psychopharmacology Suppl; 1985; 2():46-57. PubMed ID: 2987907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological mechanisms underlying tardive dyskinesia.
    Gerlach J
    Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of tardive dyskinesia.
    Gunne LM; Häggström JE
    Psychopharmacology Suppl; 1985; 2():191-3. PubMed ID: 3858799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA dysfunction in the pathophysiology of tardive dyskinesia.
    Tamminga CA; Thaker GK; Chase TN
    Psychopharmacology Suppl; 1985; 2():122-7. PubMed ID: 2987903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesolimbic system and tardive dyskinesia: new perspectives for therapy.
    Cools AR
    Mod Probl Pharmacopsychiatry; 1983; 21():111-23. PubMed ID: 6140628
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
    Miller R; Chouinard G
    Biol Psychiatry; 1993 Nov; 34(10):713-38. PubMed ID: 7904833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine, Neuroleptics, and tardive dyskinesia as paleocortical escape.
    Howard JS
    Integr Physiol Behav Sci; 1996; 31(4):306-14. PubMed ID: 8982762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia.
    Neisewander JL; Castañeda E; Davis DA; Elson HJ; Sussman AN
    Eur J Pharmacol; 1996 Jun; 305(1-3):13-21. PubMed ID: 8813526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 17. Saccadic distractibility in schizophrenic patients with tardive dyskinesia.
    Thaker GK; Nguyen JA; Tamminga CA
    Arch Gen Psychiatry; 1989 Aug; 46(8):755-6. PubMed ID: 2568826
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.